Genetic Relatedness and Superantigen Expression in Group A Streptococcus Serotype M1 Isolates from Patients with Severe and Nonsevere Invasive Diseases

ABSTRACT The relatedness of group A streptococcal (GAS) strains isolated from 35 Canadian patients with invasive disease of different severity was investigated by a variety of molecular methods. All patients were infected with M1T1 strains and, based on clinical criteria, were classified as severe (n = 21) and nonsevere (n = 14) invasive GAS infection cases. All the M1 strains studied had the emm1.0 allele and the same streptococcal pyrogenic exotoxin (Spe) genotype,speA+ speB+ speC speF+speG+ speH smeZ+ ssa. All isolates had the same speA allotype, speA2. The randomly amplified polymorphic DNA banding pattern with two different primers was identical for all strains, and pulsed field gel electrophoresis analysis showed that 33 and 30 isolates had identical banding patterns after DNA digestion with SfiI or SmaI, respectively; the nonidentical isolates differed from the main pattern by only one band. A relatively high degree of polymorphism in specific regions of the sic gene was observed among isolates; however, this polymorphism was not associated with disease severity. Likewise, although the phenotypic expression of SpeA, SpeB, and SpeF proteins varied among the M1T1 isolates, there was no correlation between the amount of Spe expressed and disease severity. Importantly, mitogenic and cytokine responses induced by partially purified bacterial culture supernatants containing a mixture of expressed superantigens were very similar for isolates from severe and nonsevere cases (P > 0.1). Together, the data indicate that highly related invasive M1T1 isolates, some indistinguishable, can cause disease of varying severity in different individuals. These findings underscore the contribution of host factors to the outcome of invasive GAS infections.

[1]  S. Holm,et al.  Genetic diversity in T1M1 group A streptococci in relation to clinical outcome of infection. , 1992, The Journal of infectious diseases.

[2]  M. Upton,et al.  Genetic heterogeneity of M type 3 group A streptococci causing severe infections in Tayside, Scotland , 1996, Journal of clinical microbiology.

[3]  B. Schwartz,et al.  The Reemergence of Severe Group A Streptococcal Disease: an Evolutionary Perspective , 1998 .

[4]  U. Andersson,et al.  Bacterial Toxin‐Induced Cytokine Production Studied at the Single‐Cell Level , 1992, Immunological reviews.

[5]  J. Musser,et al.  An outbreak of invasive group A streptococcal disease associated with high carriage rates of the invasive clone among school-aged children. , 1997, JAMA.

[6]  S. Holm,et al.  Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989. , 1992, The Journal of infectious diseases.

[7]  V. Fischetti,et al.  Streptococcal M protein: molecular design and biological behavior , 1989, Clinical Microbiology Reviews.

[8]  B. Schwartz,et al.  The changing epidemiology of invasive group A streptococcal infections and the emergence of streptococcal toxic shock-like syndrome. A retrospective population-based study. , 1993, JAMA.

[9]  R. Kaul,et al.  Plasma from patients with severe invasive group A streptococcal infections treated with normal polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production. , 1996, Journal of immunology.

[10]  J. Musser,et al.  A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C. , 1993, The Journal of clinical investigation.

[11]  Dwight R. Johnson,et al.  emm typing and validation of provisional M types for group A streptococci. , 1999, Emerging infectious diseases.

[12]  P. Huovinen,et al.  Typing of group A streptococci by random amplified polymorphic DNA analysis , 1994, Journal of Clinical Microbiology.

[13]  J. Vuopio‐Varkila,et al.  Molecular comparison of group A streptococci of T1M1 serotype from invasive and noninvasive infections in Finland. , 1997, The Journal of infectious diseases.

[14]  D. Stevens Invasive group A streptococcus infections. , 1992, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[15]  A. Norrby-Teglund,et al.  Differential induction of Th1 versus Th2 cytokines by group A streptococcal toxic shock syndrome isolates , 1997, Infection and immunity.

[16]  J. Andersson,et al.  Invasive group A streptococcal infections: T1M1 isolates expressing pyrogenic exotoxins A and B in combination with selective lack of toxin-neutralizing antibodies are associated with increased risk of streptococcal toxic shock syndrome. , 1999, The Journal of infectious diseases.

[17]  T. Proft,et al.  Identification and Characterization of Novel Superantigens from Streptococcus pyogenes , 1999, The Journal of experimental medicine.

[18]  Martin Pr,et al.  Streptococcal Serogroup: A Epidemic in Norway 1987–1988 , 1990 .

[19]  Dwight R. Johnson,et al.  Invasive group A streptococcal infections in North Carolina: epidemiology, clinical features, and genetic and serotype analysis of causative organisms. , 1997, The Journal of infectious diseases.

[20]  M. Kotb,et al.  Bacterial pyrogenic exotoxins as superantigens , 1995, Clinical microbiology reviews.

[21]  A. Norrby-Teglund,et al.  Relation between low capacity of human sera to inhibit streptococcal mitogens and serious manifestation of disease. , 1994, The Journal of infectious diseases.

[22]  B. Schwartz,et al.  Risk factors in the pathogenesis of invasive group A streptococcal infections: role of protective humoral immunity. , 1999, Infection and immunity.

[23]  J. Musser,et al.  Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease , 1995, Infection and immunity.

[24]  R. George,et al.  Extensive genetic diversity among clinical isolates of Streptococcus pyogenes serotype M5. , 1998, Microbiology.

[25]  L. Björck,et al.  Protein SIC, a Novel Extracellular Protein of Streptococcus pyogenes Interfering with Complement Function (*) , 1996, The Journal of Biological Chemistry.

[26]  A. Norrby-Teglund,et al.  Superantigenic properties of the group A streptococcal exotoxin SpeF (MF) , 1994, Infection and immunity.

[27]  J. Musser,et al.  Hypervariability generated by natural selection in an extracellular complement-inhibiting protein of serotype M1 strains of group A Streptococcus. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[28]  R. Kaul,et al.  Population-based surveillance for group A streptococcal necrotizing fasciitis: Clinical features, prognostic indicators, and microbiologic analysis of seventy-seven cases. Ontario Group A Streptococcal Study. , 1997, The American journal of medicine.

[29]  L. Burman,et al.  Outbreak of group A streptococcal bacteremia in Sweden: an epidemiologic and clinical study. , 1991, The Journal of infectious diseases.

[30]  D. Low,et al.  Streptococcal erythrogenic toxin genes: detection by polymerase chain reaction and association with disease in strains isolated in Canada from 1940 to 1991 , 1992, Journal of clinical microbiology.

[31]  N. Saunders,et al.  Rapid extraction of bacterial genomic DNA with guanidium thiocyanate , 1989 .

[32]  D. Stevens,et al.  Genetic and phenotypic diversity among isolates of Streptococcus pyogenes from invasive infections. , 1996, The Journal of infectious diseases.

[33]  J. Musser,et al.  Characterization of group A Streptococcus strains recovered from Mexican children with pharyngitis by automated DNA sequencing of virulence-related genes: unexpectedly large variation in the gene (sic) encoding a complement-inhibiting protein , 1997, Journal of clinical microbiology.

[34]  R. George,et al.  Molecular subtyping of prevalent M serotypes of Streptococcus pyogenes causing invasive disease , 1995, Journal of clinical microbiology.

[35]  S. Ichiyama,et al.  A clinical and bacteriologic investigation of invasive streptococcal infections in Japan on the basis of serotypes, toxin production, and genomic DNA fingerprints. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[36]  J. Musser,et al.  Characterization and clonal distribution of four alleles of the speA gene encoding pyrogenic exotoxin A (scarlet fever toxin) in Streptococcus pyogenes , 1991, The Journal of experimental medicine.

[37]  F. Khambaty,et al.  International dissemination of epidemic Vibrio cholerae by cargo ship ballast and other nonpotable waters , 1994, Applied and environmental microbiology.